Viatris Inc.
$16.42+1.58%(+$0.25)
TickerSpark Score
56/100
85
Valuation
30
Profitability
15
Growth
52
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VTRS research report →
52-Week Range88% of range
Low $8.19
Current $16.42
High $17.53
Companywww.viatris.com
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
- CEO
- Scott Andrew Smith
- IPO
- 1980
- Employees
- 32,000
- HQ
- Canonsburg, PA, US
Price Chart
+84.97% · this period
Valuation
- Market Cap
- $19.13B
- P/E
- -64.00
- P/S
- 1.31
- P/B
- 1.29
- EV/EBITDA
- 16.76
- Div Yield
- 2.92%
Profitability
- Gross Margin
- 34.40%
- Op Margin
- 0.96%
- Net Margin
- -2.04%
- ROE
- -1.97%
- ROIC
- 0.16%
Growth & Income
- Revenue
- $14.30B · -2.98%
- Net Income
- $-3,514,900,000 · -454.23%
- EPS
- $-3.00 · -466.04%
- Op Income
- $-2,663,100,000
- FCF YoY
- -2.01%
Performance & Tape
- 52W High
- $17.53
- 52W Low
- $8.19
- 50D MA
- $14.56
- 200D MA
- $12.34
- Beta
- 0.87
- Avg Volume
- 11.53M
Get TickerSpark's AI analysis on VTRS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 15, 26 | Le Goff Corinne | other | 39,344 |
| Apr 15, 26 | Le Goff Corinne | other | 3,644 |
| Apr 15, 26 | Le Goff Corinne | other | 1,617 |
| Apr 15, 26 | Le Goff Corinne | other | 17,450 |
| Apr 15, 26 | Le Goff Corinne | other | 39,344 |
| Apr 15, 26 | Le Goff Corinne | other | 3,643.834 |
| Mar 23, 26 | Campbell Paul | sell | 21,350 |
| Mar 6, 26 | Le Goff Corinne | other | 44,165 |
| Mar 6, 26 | Le Goff Corinne | other | 88,984 |
| Mar 6, 26 | Le Goff Corinne | other | 44,165 |
Our VTRS Coverage
We haven't published any research on VTRS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VTRS Report →Similar Companies
RDY+0.56%
Dr. Reddy's Laboratories Limited
$13.53
MRNA+5.87%
Moderna, Inc.
$48.41
ELAN+5.45%
Elanco Animal Health Incorporated
$20.88
EXAS+0.00%
Exact Sciences Corporation
$104.91
BAX+0.52%
Baxter International Inc.
$18.43
NBIX+0.11%
Neurocrine Biosciences, Inc.
$154.53
ROIV+15.30%
Roivant Sciences Ltd.
$32.53
IONS+1.91%
Ionis Pharmaceuticals, Inc.
$75.25